132 related articles for article (PubMed ID: 14750637)
1. Endoscopy-negative reflux disease: what is the value of a proton-pump inhibitor test in everyday clinical practice?
Juul-Hansen P; Rydning A
Scand J Gastroenterol; 2003 Dec; 38(12):1200-3. PubMed ID: 14750637
[TBL] [Abstract][Full Text] [Related]
2. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients.
Juul-Hansen P; Rydning A; Jacobsen CD; Hansen T
Scand J Gastroenterol; 2001 Aug; 36(8):806-10. PubMed ID: 11495074
[TBL] [Abstract][Full Text] [Related]
3. On-demand PPI requirements in patients with endoscopy-negative GERD.
Juul-Hansen P; Rydning A
J Clin Gastroenterol; 2004 Oct; 38(9):746-9. PubMed ID: 15365398
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole vs. omeprazole for gastro-oesophageal reflux disease: a pH-metric comparison.
Frazzoni M; De Micheli E; Grisendi A; Savarino V
Aliment Pharmacol Ther; 2002 Jan; 16(1):35-9. PubMed ID: 11856076
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
Monés J
Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.
Baldi F; Cappiello R; Cavoli C; Ghersi S; Torresan F; Roda E
World J Gastroenterol; 2006 Jan; 12(1):82-8. PubMed ID: 16440422
[TBL] [Abstract][Full Text] [Related]
7. Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease.
Kahrilas PJ; Hughes N; Howden CW
Gut; 2011 Nov; 60(11):1473-8. PubMed ID: 21508423
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
[TBL] [Abstract][Full Text] [Related]
9. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2003 Oct; 52(10):1397-402. PubMed ID: 12970129
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison.
Frazzoni M; Grisendi A; Lanzani A; Melotti G; De Micheli E
Dig Liver Dis; 2002 Feb; 34(2):99-104. PubMed ID: 11926567
[TBL] [Abstract][Full Text] [Related]
11. Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain.
Xia HH; Lai KC; Lam SK; Hu WH; Wong NY; Hui WM; Lau CP; Chen WH; Chan CK; Wong WM; Wong BC
Aliment Pharmacol Ther; 2003 Feb; 17(3):369-77. PubMed ID: 12562449
[TBL] [Abstract][Full Text] [Related]
12. Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients.
Calabrese C; Liguori G; Gabusi V; Gionchetti P; Rizzello F; Straforini G; Brugnera R; Di Febo G
Aliment Pharmacol Ther; 2008 Jul; 28(2):250-5. PubMed ID: 18485128
[TBL] [Abstract][Full Text] [Related]
13. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
14. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
Poe RH; Kallay MC
Chest; 2003 Mar; 123(3):679-84. PubMed ID: 12628862
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus.
Stolte M; Vieth M; Schmitz JM; Alexandridis T; Seifert E
Scand J Gastroenterol; 2000 Nov; 35(11):1125-30. PubMed ID: 11145281
[TBL] [Abstract][Full Text] [Related]
16. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
[TBL] [Abstract][Full Text] [Related]
17. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
18. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
Inadomi JM; McIntyre L; Bernard L; Fendrick AM
Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic choices in reflux disease: defining the criteria for selecting a proton pump inhibitor.
Freston JW
Am J Med; 2004 Sep; 117 Suppl 5A():14S-22S. PubMed ID: 15478848
[TBL] [Abstract][Full Text] [Related]
20. [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].
Ter Arkh; 2012; 84(2):16-21. PubMed ID: 22715656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
